HopeStage
Back to all studies
CompletedNCT06230757

Psilocybin research study for treatment-resistant depression

About this titleRead the official source — NCT06230757
Medication studyAges 21–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 75 years.

Listed locations
AuroraSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 8, 2024
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
University of Colorado, Denver
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 75 Years
Official registry ID
NCT06230757
Official title
Show the full official title

Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Aurora

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Colorado, Denver, a university.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin 25mg and Placebo (active placebo).

Who was this study for?

Listed age limits: 21 years to 75 years.

Want to explore more studies?

Explore studies